Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingxin Gong

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 13, 2024
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer PatientsYusheng Guo, Tianxiang Li, Bingxin Gong, et al.
BMC Cancer|April 25, 2024
Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic reviewYusheng Guo, Yao Pan, Jiayu Wan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2025
Association between magnetic resonance imaging-measured bone marrow cellularity and clinical outcomes among patients with cervical cancer treated with programmed cell death protein-1 inhibitorsJie Lou, Yi Li, Ruijie Li, et al.
British Journal of Cancer|August 15, 2025
The lung immune prognostic index stratifies the occurrence of checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients: a multi-institutional cohort studyBingxin Gong, Yusheng Guo, Qi Wan, et al.
International Immunopharmacology|January 10, 2025
Immunotherapy improved the efficacy of TACE or TACE plus MTTs in HCC patients: A meta-analysisYusheng Guo, Zhenliang Pan, Xuefeng Kan, et al.
Frontiers in Immunology|July 12, 2024
Association between tertiary lymphoid structures and clinical outcomes in cancer patients treated with immune checkpoint inhibitors: an updated meta-analysisLingli Li, Yusheng Guo, Bingxin Gong, et al.
Abdominal Radiology (New York)|April 21, 2026
Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort studyYanjie Yang, Bingxin Gong, Xiangchuang Kong, et al.
Frontiers in Immunology|December 8, 2025
The crossroads of inflammation and nutrition: predicting neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma patientsGuisheng Zhang, Bingxin Gong, Yusheng Guo, et al.
Scientific Reports|April 1, 2025
Prognostic value of sarcopenia in patients with unresectable colorectal liver metastases after drug-eluting beads transcatheter arterial chemoembolization: a single center retrospective studyFuquan Wang, Bingxin Gong, Lei Chen, et al.
Neurosurgical Review|April 8, 2026
MRI semantic features as prognostic indicators and biological mechanism insights in glioblastoma multiformeYuxi Gui, Jie Lou, Yusheng Guo, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 13, 2024
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer PatientsYusheng Guo, Tianxiang Li, Bingxin Gong, et al.
BMC Cancer|April 25, 2024
Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic reviewYusheng Guo, Yao Pan, Jiayu Wan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2025
Association between magnetic resonance imaging-measured bone marrow cellularity and clinical outcomes among patients with cervical cancer treated with programmed cell death protein-1 inhibitorsJie Lou, Yi Li, Ruijie Li, et al.
British Journal of Cancer|August 15, 2025
The lung immune prognostic index stratifies the occurrence of checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients: a multi-institutional cohort studyBingxin Gong, Yusheng Guo, Qi Wan, et al.
International Immunopharmacology|January 10, 2025
Immunotherapy improved the efficacy of TACE or TACE plus MTTs in HCC patients: A meta-analysisYusheng Guo, Zhenliang Pan, Xuefeng Kan, et al.
Frontiers in Immunology|July 12, 2024
Association between tertiary lymphoid structures and clinical outcomes in cancer patients treated with immune checkpoint inhibitors: an updated meta-analysisLingli Li, Yusheng Guo, Bingxin Gong, et al.
Abdominal Radiology (New York)|April 21, 2026
Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort studyYanjie Yang, Bingxin Gong, Xiangchuang Kong, et al.
Frontiers in Immunology|December 8, 2025
The crossroads of inflammation and nutrition: predicting neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma patientsGuisheng Zhang, Bingxin Gong, Yusheng Guo, et al.
Scientific Reports|April 1, 2025
Prognostic value of sarcopenia in patients with unresectable colorectal liver metastases after drug-eluting beads transcatheter arterial chemoembolization: a single center retrospective studyFuquan Wang, Bingxin Gong, Lei Chen, et al.
Neurosurgical Review|April 8, 2026
MRI semantic features as prognostic indicators and biological mechanism insights in glioblastoma multiformeYuxi Gui, Jie Lou, Yusheng Guo, et al.
Pageof 3